ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 20 April to 26 April 2026

The 10 most important of the 108 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Cardiology · Lancet · 2026-04-25

IPD meta-analysis of 46 RCTs (285,124 participants): each 5 mm Hg systolic reduction lowered major cardiovascular events similarly with CKD (HR 0.91) and without (HR 0.90), across CKD stages 1–5, but less with CKD plus diabetes (HR 0.96).

Meta-analysisn = 285,124
Zeng et al. Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis
Psychiatry · J Affect Disord · 2026-04-22

In a Hong Kong cohort of 124,854 adults starting antidepressants, SSRI initiators had no significant difference in stroke risk vs non-SSRI initiators (HR 0.95, 95% CI 0.77-1.17); a meta-analysis with 5 other observational studies agreed (RR 0.94, 0.83-1.06).

Meta-analysisn = 124,854
Sun et al. Risk of stroke among individuals on selective serotonin reuptake inhibitors (SSRIs) versus non-SSRI antidepressants: a population-based retrospective cohort study and meta-analysis
Psychiatry · J Affect Disord · 2026-04-26

Systematic review of 13 studies (6 meta-analysed, n=5,657): circulating GDF-15 was higher in adults with depression than controls (SMD 0.39, 95% CI 0.19–0.58), with moderate-to-high heterogeneity; links with severity were inconsistent.

Meta-analysisn = 55,985
Jones-Murphy et al. Circulating Growth Differentiation Factor-15 (GDF-15) levels in depressive disorders - A systematic review and meta-analysis of the association between GDF-15 and depression in adult populations
Rheumatology · Semin Arthritis Rheum · 2026-04-21

Meta-analysis of 7 observational studies (21,244 patients with rheumatoid arthritis): selective JAK1 inhibitors were associated with lower discontinuation than pan-JAK inhibitors (HR 0.72), mainly for lack of efficacy (HR 0.68); adverse-event and infection stops were similar.

Meta-analysisn = 21,244
Lee et al. Superior drug retention of selective JAK1 inhibitors compared to pan-JAK inhibitors in rheumatoid arthritis: A meta-analysis of real-world evidence
Respiratory · Lancet Respir Med · 2026-04-22

Systematic review of 44 trials (9704 adults; 37 trials meta-analysed for intubation) in acute hypoxaemic respiratory failure: vs standard oxygen, CPAP (OR 0.45), HFNC (OR 0.61) and bilevel NIPPV (OR 0.60) probably reduce intubation; CPAP and HFNC may reduce mortality.

Meta-analysisn = 9,704
Lee et al. Non-invasive respiratory supports and criteria for intubation in randomised trials of acute hypoxaemic respiratory failure: a systematic review and network meta-analysis
Neurology · Cephalalgia · 2026-04-21

Network meta-analysis of 18 RCTs (7281 adults with migraine and prior preventive failure): vs placebo, fremanezumab, eptinezumab, galcanezumab, atogepant and erenumab may most reduce monthly migraine days (MD −2.20 to −3.35); low-certainty evidence.

Meta-analysisn = 7,281
Khalili et al. Effectiveness and tolerability of pharmacological prophylaxis in migraine patients with prior preventive treatment failure: A systematic review and network meta-analysis of randomized controlled trials

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.